- Free from Publisher W Yang, Q Ji, D Zhu, J Yang, L Chen, Z Liu, D … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—A1C decreased significantly in both groups (BID group −2.48 ±
0.07%; TID group −2.81 ± 0.07%). Thrice-daily BIAsp 30 showed superiority in
A1C improvement (−0.33% [95% CI −0.53 to −0.13]; P < 0.01) and helped ... Cited by 8 - Related articles - BL Direct - All 6 versions
P Valensi, M Benroubi, V Borzi, J Gumprecht … - Int J Clin Pract, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 7 - Related articles - All 3 versions
[CITATION] Current diabetes care status in China: an observational survey study
CY Pan, WY Yang, WP Jia, JP Weng, H Tian - The 43rd Annual Meeting of the EASD, Amsterdam, …, 2007 Cited by 2 - Related articles
SK Sharma, SR Joshi, A Kumar, AG … - JAPI, 2008 - japi.org Aim: The Physicians' Routine Evaluation of Safety and Efficacy of NovoMix® 30
Therapy (PRESENT ) study was done to assess the safety and effectiveness of
biphasic insulin aspart 30 (BIAsp 30) in patients with type 2 diabetes ... Cited by 3 - Related articles - View as HTML - All 4 versions
J Yang - Diabetes Care, 2008 - Am Diabetes Assoc OBJECTIVE — To assess the efficacy and safety of twice- and thrice-daily
biphasic insulin aspart 30 (BIAsp 30) in Chinese subjects with type 2 diabetes
inadequately controlled with oral antidiabetes drugs (OADs). Related articles
WM Bebakar, CC Chow, KA Kadir, S … - Diabetes Obes Metab, 2007 - interscience.wiley.com Methods: This 26-week, multi-centre, open-labelled, randomized, two-arm parallel
trial consisted of a 2-week screening period, followed by 24 weeks of treatment.
Subjects randomized to BIAsp30 treatment (n = 129) received BIAsp30 once ... Cited by 9 - Related articles - All 3 versions
R Pradeepa, M Rema, J Vignesh, M Deepa, … - Diabetic Medicine, 2008 - pt.wkhealth.com Results: The overall prevalence of DN was 26.1% (age-adjusted 13.1%) with no
significant difference in gender. The prevalence of neuropathy was significantly
higher in KD subjects compared with NDD subjects (27.8 vs. 19.5%, P = ... Cited by 8 - Related articles - BL Direct - All 5 versions
陈攀， 黄涛 - 西南军医, 2009 - journal.shouxi.net Abstract Objective To compare the curative effect and safety between NovoRapid
30 and Novolin 30R in treating patients with type 2 diabetes mellitus (T2DM) who
had just started the treatment with the injection of insulin.Methods 60 ... Related articles - Cached - All 3 versions
J Gumprecht, G Żurawska, B Wolnik, G Dzida - Endokrynologia Polska, 2008 - viamedica.pl Janusz Gumprecht MD, Ph.D. Department of Internal Diseases, Diabetology and
Nephrology, Medical University of Silesia, ul. 3-go Maja 13–15, 41–800
Zabrze, tel.: +48 32 271 25 11, fax: +48 32 271 46 17, e-mail: ... Related articles - View as HTML - All 3 versions
Y Wen-ying, JI Qiu-he, ZHU Da-long, Y Jin-kui … - Chinese Medical Journal, 2009 - cmj.org The aim of this study was a head-to-head comparison of BID versus TID BIAsp 30
dosing in Chinese insulin-naïve subjects with type 2 diabetes after at least
six-month inadequately controlled by OAD treatment. The published data from ... Related articles - View as HTML - All 3 versions
